| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Kiniksa Pharmaceuticals International, Plc's insiders have reduced their positions by a net 4,600 shares worth roughly $369K.
Classified under Pharmaceuticals (Health Care sector), KNSA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.74M | - | - | |
| CEO | 92.3K | $7.32M | - | |
| Other | 69.9K | $5.54M | - | |
| Other | 29.1K | $2.33M | - | |
| Other | 23.1K | $1.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE10b5-1 | 200 | $42.89 | $8,578.00 | -0.9% | +2.3% | - | |
| Nov 17, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE10b5-1 | 12,470 | $41.24 | $514,224.10 | -35.4% | +9.6% | - | |
| Nov 12, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE10b5-1 | 19,900 | $40.94 | $814,706.00 | -39.0% | +10.2% | - | |
| Oct 31, 2025 | Paolini John F.51 | Chief Medical Officer | Sale+OE10b5-1 | 82,542 | $37.14 | $3,065,609.88 | -57.4% | +18.8% | - | |
| Oct 28, 2025 | Ragosa Mark | Chief Financial Officer | Sale+OE10b5-1 | 100 | $41.00 | $4,100.00 | -0.3% | +9.6% | +94.6% | |
| Oct 22, 2025 | Patel Sanj K | Chairman &CEO | Sale+OE10b5-1 | 257,969 | $38.86 | $10,023,531.59 | -69.8% | +5.5% | +107.7% | |
| Oct 20, 2025 | Megna Michael R | Chief Accounting Officer | Sale+OE10b5-1 | 50,490 | $38.87 | $1,962,781.45 | -65.1% | +5.2% | +113.3% | |
| Oct 14, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE10b5-1 | 12,368 | $37.67 | $465,843.22 | -30.1% | +8.5% | +108.1% | |
| Sep 29, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE10b5-1 | 42,000 | $38.33 | $1,609,860.00 | -54.9% | +5.7% | +95.3% | |
| Sep 15, 2025 | Tessari Eben | Chief Operating Officer | Sale+OE10b5-1 | 16,400 | $36.46 | $597,975.80 | -32.2% | +13.6% | +105.6% |